Breaking News Instant updates and real-time market news.

DB

Deutsche Bank

$18.38

-0.65 (-3.42%)

, C

Citi

$59.59

-0.78 (-1.29%)

07:20
03/21/17
03/21
07:20
03/21/17
07:20

Deutsche Bank may be fined over foreign exchange trades, Bloomberg reports

Deutsche Bank (DB) disclosed in a filing Monday that the CFTC has closed its foreign exchange investigation of the bank, and the DOJ, Criminal Division, Fraud Section, has closed its criminal inquiry concerning possible violations of federal criminal law in connection with the foreign exchange markets. However, the Federal Reserve and the New York Department of Financial Services, which had their own probes as well, are in the final stages of their own reviews of the bank's conduct in the foreign exchange market to determine what fines, if any, the bank should pay, according to Bloomberg, citing a person familiar with the matter. Currency investigations lead to five other big banks - Citi (C), JPMorgan (JPM), Barclays (BCS), Royal Bank of Scotland (RBS) and UBS (UBS) - to plead guilty in 2015 in connection with a DOJ probe and Deutsche was the largest participant in the foreign exchange market to escape Justice Department action, though the bank still has to contend with a civil suit against it and 15 other banks, the report added. Reference Link

DB

Deutsche Bank

$18.38

-0.65 (-3.42%)

C

Citi

$59.59

-0.78 (-1.29%)

BCS

Barclays

$11.19

-0.18 (-1.58%)

JPM

JPMorgan

$90.03

-0.65 (-0.72%)

RBS

RBS

$5.92

-0.12 (-1.99%)

UBS

UBS

$15.79

-0.25 (-1.56%)

  • 13

    Apr

  • 14

    Jul

  • 25

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

DB Deutsche Bank
$18.38

-0.65 (-3.42%)

01/06/17
01/06/17
UPGRADE
Target $67

Outperform
Luxoft upgraded to Outperform at Wedbush
As previously reported, Wedbush analyst Moshe Katri upgraded Luxoft (LXFT) to Outperform from Neutral to reflect not only an improving spending outlook for the Financial Services sector, but also spending improvements at UBS (UBS) and Deutsche Bank (DB), which collectively account for roughly 43% of the company's revenue base. He also raised his price target on the shares to $67 from $62.
12/19/16
SBSH
12/19/16
DOWNGRADE
SBSH
Sell
Deutsche Bank downgraded to Sell from Neutral at Citi
Citi analyst Andrew Coombs downgraded Deutsche Bank to Sell saying the shares have run "too far, too fast." Since the U.S. election, the stock is up 41%, Coombs tells investors in a research note. The further the share price rises, the less dilutive any future potential capital raise becomes, the analyst writes. He raised his price target for Deutsche shares to EUR 17 from EUR 15.
09/30/16
09/30/16
NO CHANGE

Correction: Deutsche Bank credit upgraded to Neutral at BofA/Merrill
BofA/Merrill upgraded Deutsche Bank's credit to Neutral, not the equity.
09/29/16
COWN
09/29/16
NO CHANGE
COWN
DoJ will not destabilize Deutsche Bank, says Cowen
Cowen analyst Jaret Seiberg sees little practical or political upside for the Justice Department to press Deutsche Bank for a penalty that is so large it could destabilize the bank and create a new financial crisis. He expects the penalty for violations related to mortgage-backed securities to be structured below the speculated $14B that seems to have alarmed the market. Seiberg adds both sides have incentives to reach a deal quickly.
C Citi
$59.59

-0.78 (-1.29%)

03/03/17
EVER
03/03/17
DOWNGRADE
Target $63
EVER
In Line
Citi downgraded to In Line from Buy at Evercore ISI
Evercore ISI changed its rating system to Outperform, In Line and Underperform. Analyst Glenn Schorr said Citi has been executing well and will continue to improve but downgraded shares to In Line. He believes shares will not keep pace with large bank peers given investor preference for less EM exposure, less Mexico, better US rate leverage, and potential for book loss related to lower US tax rates. Schorr's price target on Citi goes to $63 from $62
02/02/17
SBSH
02/02/17
DOWNGRADE
Target $83
SBSH
Neutral
Citi downgrades Ralph Lauren to Neutral on CEO departure
Citi analyst Kate McShane downgraded Ralph Lauren to Neutral from Buy saying the departure of CEO Stefan Larsson feels like a "giant step back." The CEO change, coupled with a lack of transparency, brings uncertainty to the company's long-term growth strategy, McShane tells investors in a post-earnings research note. She believes finding a replacement could be challenging since the new CEO's vision still has to fit with that of Mr. Lauren. The analyst cut her price target for the shares to $83 from $114. In midday trading, Ralph Lauren is down 11%, or $9.99, to $77.38.
02/01/17
MSCO
02/01/17
NO CHANGE
MSCO
Overweight
Citi offers most compelling value, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck, said Citi is her top pick and the biggest beneficiary of financial regulation, given its complex global footprint and the largest excess capital versus in the group. Graseck believes Citi's exposure to Mexico and potential $3B in DTA writedowns are manageable and believes fully optimizing capital could drive a 20% increase in earnings. The analyst said Citi offers the most compelling value and reiterates her Overweight rating and $70 price target price target on shares.
02/01/17
BERN
02/01/17
NO CHANGE
BERN
Citi Mexico exposure appears 'manageable,' says Bernstein
Noting that the Trump Administration is in the process of changing U.S. policies towards Mexico, Bernstein analyst John Mcdonald reports that Citi obtains 8%-9% of its revenue from the country. Still, the analyst believes that Citi's exposure to Mexico "looks manageable, short of a severe economic pullback in the region." McDonald says that Citi's "diversified international exposure and Banamex's long history of operating successfully in Mexico" limit the bank's risk in the country. He keeps a $68 price target and an Outperform rating on the shares.
BCS Barclays
$11.19

-0.18 (-1.58%)

01/30/17
01/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Colgate-Palmolive (CL) downgraded to Neutral from Buy at Citi with analyst Wendy Nicholson saying the sales the "breadth of the top-line weakness" in the company's fourth quarter results is "very disconcerting." Even with the 5% post-earnings pullback, Colgate shares are still not cheap, Nicholson tells investors in a research note. She lowered her price target for the shares to $70 from $76. 2. Air Products (APD) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he believes the catalyst that led to identifiable margin improvement last quarter may have substantially played out and the company is now more exposed to sluggish economic trends that have underpinned his cautious thinking on Praxair (PX). Manthey lowered his price target to $140 from $146 on Air Products shares. 3. Barclays (BCS) downgraded to Sell from Hold at Berenberg with analyst Peter Richardson citing valuation and high investment banking expectations reflected in shares. 4. Symantec (SYMC) reinstated with a Neutral from Buy at Citi with analyst Walter Pritchard downgrading Symantec (SYMC) to Neutral from Buy after reinstating coverage of the name. The analyst sees "weaker strategic merit" in the company's LifeLock (LOCK) acquisition relative to the Blue Coat deal. He also believes success is being priced in with investors looking for $2.00-plus in earnings power. Pritchard raised his price target for Symantec shares to $29 from $26.50. 5. CONSOL (CNX) downgraded to Hold from Buy at SunTrust. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/17
BREN
01/30/17
DOWNGRADE
BREN
Sell
Barclays downgraded to Sell from Hold at Berenberg
Berenberg analyst Peter Richardson downgraded Barclays to Sell citing valuation and high investment banking expectations reflected in shares.
03/16/17
MSCO
03/16/17
UPGRADE
MSCO
Overweight
Barclays upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Christopher Manners upgraded Barclays to Overweight with an increased price target of 280p.
03/17/17
03/17/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Adobe (ADBE) upgraded to Buy from Hold at Wunderlich with analyst Ryan Macdonald citing the company's better than expected first quarter results. The analyst raised his price target for the shares to $145 from $115. 2. L Brands (LB) upgraded to Outperform from Market Perform at FBR Capital with analyst Susan Anderson saying her survey work shows that Victoria Secret has not lost share over the past year and that same-store-sales will be better than expected in the second half of 2017. 3. Vertex (VRTX) upgraded to Outperform from Market Perform at JMP Securities with analyst Liisa Bayko saying the company's triple combo data this year could expand its cystic fibrosis patient pool by greater than 50%. Positive triple combo data could make Vertex a takeover target, Bayko adds. 4. Dean Foods (DF) upgraded to Overweight from Neutral at JPMorgan with analyst Ken Goldman raising his estimates to reflect lower raw dairy costs. The outlook for Dean's largest input, Class I milk, has softened in recent months, Goldman tells investors in a research note. The analyst raised his price target for the shares to $22 from $20. 5. Barclays (BCS) upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JPM JPMorgan
$90.03

-0.65 (-0.72%)

01/20/17
CHLM
01/20/17
NO CHANGE
Target $10
CHLM
Buy
CPI Card may benefit from Amazon, Chase metal credit cards, says Craig-Hallum
Craig-Hallum analyst Brad Berning notes that Amazon's (AMZN) announcement that it is upping its cash back program to 5% on its new Visa (V) Prime Rewards cards contained a statement "buried within it" that Chase (JPM) would issue metal cards on its behalf. With Chase Sapphire and now Amazon Signature Rewards issuing metal credit cards, the analyst believes "the race is on" for issuers to differentiate themselves for key valuable customers. CPI Card Group (PMTS) previously announced that it would start taking orders in Q1 on this new product line, Berning points out, adding that he believes the greater adoption of metal cards makes it more likely that CPI Card Group will be able to get involved. He reiterates a Buy rating and $10 price target on CPI Card Group's shares.
01/17/17
01/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Neutral from Buy at UBS with analyst Eric Sheridan downgrading Twitter after he lowered his advertising revenue estimates for 2017 and 2018 to reflect lower advertising ARPU paired with muted core MAU growth. Sheridan lowered his price target to $18 from $22 on Twitter shares. 2. JPMorgan (JPM) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl saying he does not see near-term earnings catalysts to move JPMorgan's returns and earnings meaningfully higher absent tax reform or broad-scale deregulation and is downgrading the stock to Market Perform from Outperform as he prefers to take a wait-and-see approach. Kleinhanzl edged his price target on JPMorgan shares up to $89 from $88. 3. Chipotle (CMG) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe saying that his attendance at the ICR Conference underscored the difficult environment hitting many operating companies, including Chipotle. 4. Nordstrom (JWN) downgraded to Hold from Buy at Stifel with with analyst Richard Jaffe saying he believes that the company's holiday sales were weaker than previously expected. 5. OUTFRONT Media (OUT) downgraded to Neutral from Buy at Goldman with analyst Drew Borst citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/24/17
02/24/17
UPGRADE
Target $140

Outperform
Intuit upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Michael Nemeroff upgraded Intuit (INTU) to Outperform from Neutral given his expectations for a normal close to the 2016 tax season, in which he expects the company to at least maintain its share of the tax prep market and continued strong growth in its small business segment, particularly given new and expanded partnerships with financial institutions such as JPMorgan Chase (JPM), Wells Fargo (WFC), and others. The analyst also raised his price target on Intuit's shares to $140 from $109.
02/07/17
DAIW
02/07/17
UPGRADE
DAIW
Outperform
JPMorgan upgraded to Outperform from Hold at Daiwa
RBS RBS
$5.92

-0.12 (-1.99%)

02/07/17
DBAB
02/07/17
UPGRADE
DBAB
Hold
RBS upgraded to Hold from Sell at Deutsche Bank
03/02/17
BREN
03/02/17
UPGRADE
BREN
Buy
RBS upgraded to Buy from Hold at Berenberg
Price target 275p.
03/02/17
BREN
03/02/17
UPGRADE
BREN
Buy
RBS upgraded to Buy from Hold at Berenberg
03/02/17
03/02/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exxon Mobil (XOM) upgraded to Neutral from Underperform at Credit Suisse with analyst Edward Westlake saying that after underperformance versus the S&P, the stock has option value. The analyst also raised his price target on the shares to $83 from $78. 2. RBS (RBS) upgraded to Buy from Hold at Berenberg. 3. Windstream (WIN) upgraded to Hold from Underperform at Jefferies with analyst Scott Goldman saying he sees less risk to estimates following management's 2017 guidance. The analyst upped his price target for the shares to $7.50 from $6. 4. Sarepta (SRPT) upgraded to Outperform from Market Perform at Leerink with analyst Joseph Schwartz saying the stock now reflects "reasonable expectations" for the Exondys launch. Management's new revenue guidance looks "highly conservative," Schwartz tells investors in a research note. The analyst believes share upside could come from Exondys 51 approval in Europe and/or successful development of follow-on antisense candidates. He raised his price target for Sarepta shares to $47 from $27. 5. Estee Lauder (EL) upgraded to Overweight from Neutral at Piper Jaffray with analyst Stephanie Wissink saying the growth is de-risked following the guidance reset. The analyst is "bullish" on the prospects for double digit earnings growth for investors that can look into FY18. She raised her price target for the shares to $95 from $81. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
UBS UBS
$15.79

-0.25 (-1.56%)

02/07/17
02/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Buy from Neutral at Citi with analyst Robyn Karnauskas saying the Alzheimer's Phase 2 data already reported and no Phase 3 results until 2019/20, upside in the stock rests on the stability of Biogen's multiple sclerosis business and success of the Spinraza launch in spinal muscular atrophy. 2. Caterpillar (CAT) upgraded to Overweight from Equal Weight at Barclays with analyst Robert Wertheimer saying investors likely will never get a chance to buy the company's revenue with as much upside as in 2017. 3. Sysco (SYY) upgraded to Overweight from Neutral at JPMorgan with analyst John Ivankoe saying the shares should be bought in the low $50s. He raised his price target for the shares to $57 from $55. 4. Nokia (NOK) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. UBS (UBS) upgraded to Neutral from Underperform at BofA/Merrill with analyst Andrew Stimpson saying negative catalysts have played out. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/17
BOFA
02/07/17
UPGRADE
Target $17
BOFA
Neutral
UBS upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst Andrew Stimpson upgraded UBS to Neutral saying negative catalysts have played out.
01/11/17
SOCG
01/11/17
UPGRADE
SOCG
Buy
UBS upgraded to Buy from Hold at Societe Generale

TODAY'S FREE FLY STORIES

AEL

American Equity

$28.06

0.06 (0.21%)

06:34
07/25/17
07/25
06:34
07/25/17
06:34
Downgrade
American Equity rating change  »

American Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

TRMB

Trimble

$38.20

0.49 (1.30%)

06:34
07/25/17
07/25
06:34
07/25/17
06:34
Hot Stocks
Trimble adds first partner in Latin America to Vantage network »

Trimble announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 02

    Aug

  • 14

    Aug

SVU

Supervalu

$3.25

-0.01 (-0.31%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Hot Stocks
Supervalu sees FY18 net earnings from continuing operations $51M-$70M »

Sees FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

BIIB

Biogen

$284.70

1.78 (0.63%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Earnings
Biogen raises FY17 adjusted EPS view to $20.80-$21.40 from $20.45-$21.25 »

FY17 consensus $20.38.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GPK

Graphic Packaging

$13.77

0.04 (0.29%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Earnings
Graphic Packaging reports Q2 adj. EPS 15c, consensus 15c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PHM

PulteGroup

$24.42

0.11 (0.45%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Hot Stocks
Breaking Hot Stocks news story on PulteGroup »

PulteGroup believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SVU

Supervalu

$3.25

-0.01 (-0.31%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
Supervalu reports Q1 adjusted EPS 9c, consensus 11c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MORE

Monogram Residential Trust

$11.95

0.01 (0.08%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Downgrade
Monogram Residential Trust rating change  »

Monogram Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$24.42

0.11 (0.45%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
PulteGroup reports Q2 adjusted EPS 47c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TEAM

Atlassian

$36.41

0.66 (1.85%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Upgrade
Atlassian rating change  »

Atlassian upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

BIIB

Biogen

$284.70

1.78 (0.63%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Earnings
Biogen reports Q2 adjusted EPS $5.04, consensus $4.41 »

Reports Q2 revenue $3.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GOOG

Alphabet

$980.34

7.42 (0.76%)

, GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Alphabet earnings…

GOOG

Alphabet

$980.34

7.42 (0.76%)

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Hot Stocks
Eli Lilly will pursue new standard-of-care changing therapies in oncology »

Eli Lilly is providing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:29
07/25/17
07/25
06:29
07/25/17
06:29
Earnings
Eli Lilly raises FY17 EPS view to $4.10-$4.20 from $4.05-$4.15, consensus $4.12 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

, BMWYY

BMW

$30.72

-0.8 (-2.54%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Periodicals
Daimler directors to discuss alleged German auto cartel, Reuters says »

Daimler's (DDAIF)…

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

BMWYY

BMW

$30.72

-0.8 (-2.54%)

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

POAHY

Porsche

$5.82

-0.03 (-0.51%)

AUDVF

Audi AG

$835.60

-4.8 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WERN

Werner

$29.20

-0.35 (-1.18%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Upgrade
Werner rating change  »

Werner upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TNTR

Tintri

$6.95

0.16 (2.36%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Tintri initiated  »

Tintri initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BY

Byline Bancorp

$20.85

0.13 (0.63%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Byline Bancorp initiated  »

Byline Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Earnings
Eli Lilly reports Q2 EPS $1.11, consensus $1.05 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

NCMGY

Newcrest Mining

$15.72

0.12 (0.77%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Upgrade
Newcrest Mining rating change  »

Newcrest Mining upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPNC

Spectranetics

$38.50

0.05 (0.13%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Downgrade
Spectranetics rating change  »

Spectranetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMP

Tompkins Financial

$78.41

-0.14 (-0.18%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Upgrade
Tompkins Financial rating change  »

Tompkins Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$40.61

-0.2 (-0.49%)

, AAPL

Apple

$152.09

1.82 (1.21%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Periodicals
Sony restructures television production unit, WSJ reports »

Sony Pictures…

SNE

Sony

$40.61

-0.2 (-0.49%)

AAPL

Apple

$152.09

1.82 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LLY

Eli Lilly

$84.74

0.08 (0.09%)

, INCY

Incyte

$138.27

4.05 (3.02%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Hot Stocks
Eli Lilly, Incyte resubmit baricitinib NDA to FDA »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$84.74

0.08 (0.09%)

INCY

Incyte

$138.27

4.05 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 11

    Sep

SSB

South State

$83.90

0.7 (0.84%)

06:19
07/25/17
07/25
06:19
07/25/17
06:19
Upgrade
South State rating change  »

South State upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 18

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.